| Literature DB >> 24712687 |
Giovanni De Caridi1, Mafalda Massara1, Antonio David2, Massimiliano Giardina2, Michele La Spada1, Francesco Stilo1, Francesco Spinelli1, Raffaele Grande3, Lucia Butrico3, Stefano de Franciscis3,4, Raffaele Serra3,4.
Abstract
Critical lower limb ischaemia is a diffuse pathology that could cause claudication, severe ischaemic pain and tissue loss. The common treatment includes modification of risk factors, pharmacological therapy and endovascular or surgical revascularisation of the lower limb to restore a pulsatile flow distally. Spinal cord stimulator is seen as a valid alternative in patients unsuitable for revascularisation after endovascular or surgical revascularisation failure and as adjuvant therapy in the presence of a functioning bypass in patients with extensive tissue loss and gangrene presenting a slow and difficult wound healing. We report our experience on spinal cord stimulation (SCS) indication and implantation in patients with critical lower limb ischaemia, at a high-volume centre for the treatment of peripheral arterial disease.Entities:
Keywords: Critical lower limb ischaemia; Pain relief; Spinal cord stimulation; Surgical revascularisation; Wound healing
Mesh:
Year: 2014 PMID: 24712687 PMCID: PMC7949687 DOI: 10.1111/iwj.12272
Source DB: PubMed Journal: Int Wound J ISSN: 1742-4801 Impact factor: 3.315